Neuromodulators for pain management in rheumatoid arthritis (Q24203885)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956614&resulttype=core&format=json

13 May 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956614&resulttype=core&format=json

13 May 2020

3

Rachelle Buchbinder

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956614&resulttype=core&format=json

13 May 2020

author name string

Bethan L Richards

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956614&resulttype=core&format=json

Cochrane Database of Systematic Reviews

13 May 2020

publication date

18 January 2012

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956614&resulttype=core&format=json

13 May 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956614&resulttype=core&format=json

13 May 2020

page(s)

CD008921

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956614&resulttype=core&format=json

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.

13 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

A double-blind study of the simple analgesic nefopam in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Efficacy of Intra-Articular Botulinum Toxin Type A in Painful Knee Osteoarthritis: A Pilot Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

The effects of intra-articular botulinum toxin on sacroiliac, cervical/lumbar facet and sterno-clavicular joint pain and C-2 root and lumbar disc pain: a case series of 11 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Intra-articular Botulinum Toxin Type A: a new approach to treat arthritis joint pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Comparison of phenytoin and gold as second line drugs in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: A report of two cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Ketamine as an adjuvant to opioids for cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Perioperative ketamine for acute postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Topiramate in the treatment of neuropathic pain in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Control of pain initiation by endogenous cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

What is new in neuropathic pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Clinical trial registration: a statement from the International Committee of Medical Journal Editors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Pharmacologic management of neuropathic pain: evidence-based recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Enhanced reactivity to pain in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Evidence of the involvement of dopamine in the analgesic effect of nefopam

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Nefopam for the prevention of postoperative pain: quantitative systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Targeting the N-methyl-D-aspartate receptor for chronic pain management. Preclinical animal studies, recent clinical experience and future research directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Fatal aplastic anemia in a patient treated with carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Measurement of patient outcome in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Nefopam: a review of its pharmacological properties and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Single dose oral nefopam for acute postoperative pain in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Preclinical science regarding cannabinoids as analgesics: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Systematic review and meta-analysis of cannabis treatment for chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Systematic review of topical capsaicin for the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

"Evidence" in chronic pain--establishing best practice in the reporting of systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Characterisation of capsaicin-induced mechanical hyperalgesia as a marker for altered nociceptive processing in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Cannabinoid receptors and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Botulinum toxin for shoulder pain: a cochrane systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Investigating the relationship between pain and discomfort and quality of life, using the WHOQOL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Gabapentin for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Lamotrigine for acute and chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Neuropathic pain: aetiology, symptoms, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008921.PUB2

Botulinum toxin injections for low-back pain and sciatica

21 January 2018

1 reference

12 December 2020

Involvement of central serotonergic pathways in nefopam-induced antinociception

1 reference

12 December 2020

Nefopam in rheumatoid arthritis. Results of a double-blind placebo controlled study

1 reference

12 December 2020

Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.

1 reference

12 December 2020

Cannabinoids and pain

1 reference

12 December 2020

Herbal therapy for treating rheumatoid arthritis

1 reference

12 December 2020

Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire

1 reference

12 December 2020

What is pain management, and what is its relevance to the rheumatologist?

1 reference

12 December 2020

Repeat Injections of Intra-Articular Botulinum Toxin A for the Treatment of Chronic Arthritis Joint Pain

1 reference

12 December 2020

Treatment of arthritis with topical capsaicin: a double-blind trial

1 reference

12 December 2020

Spinal and supraspinal sites for morphine and nefopam analgesia in the mouse

1 reference

12 December 2020

Cannabinoid mechanisms of pain suppression.

1 reference

12 December 2020

Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands

1 reference

12 December 2020

Topical capsaicin-pharmacology and potential role in the treatment of temporomandibular pain.

1 reference

12 December 2020

Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority

1 reference

12 December 2020

10.1002/14651858.CD008921.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

4987488

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956614&resulttype=core&format=json

13 May 2020

4987488

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6956614&resulttype=core&format=json

13 May 2020

2 references

Consolidated OpenCitations Corpus – April 2017

4987488